Our Featured Experts

Ann H. Klopp, MD, PhD
Aditya Bardia, MD, MPH
Dr. Bardia on Sacituzumab Govitecan in TNBC
Aditya Bardia, MD, MPH, director of Precision Medicine at the Center for Breast Cancer, Massachusetts General Hospital Cancer Center, and assistant professor of medicine, Harvard Medical School, discusses the potential of sacituzumab govitecan in patients with triple-negative breast cancer (TNBC).
Oncology Specialists
Publication Bottom Border
Border Publication